Dr. Azka Ali, MD

Dr. Ali practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Ali's NPI, 1104203645, was assigned on May 5, 2015. Dr. Ali holds Ohio license 35.144887.

Dr. Ali's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Ali's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Ali is also affiliated with Lutheran Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Ali to 3 more hospitals, 2 clinical labs and 1 group practice or clinic, each named with a free account. Dr. Ali's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ali practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Ali's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Ali is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Ali's licenses on file in 2 states: Ohio and Florida.

CMS data shows 216 Medicare services from Dr. Ali across 7 procedure codes in 2024, for 119 Medicare patients. Medicare paid $18,065 for them.

CMS counts 119 Medicare patients who saw Dr. Ali in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have cancer, and 72% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ali's median patient age at 61, with 85% women.

In 2024, Dr. Ali wrote 581 Medicare Part D claims for 125 patients. 77% of them were for generic drugs. CMS names the drug for 413 of them, across 11 drugs with 11 or more claims each, at $1,441,271 in total drug cost. In 2023, CMS named 189 claims across 7 drugs.

Dr. Ali accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ali as offering telehealth.

Dmand AI links 21 papers to Dr. Ali, published from 2016 to 2024. 2023 was the busiest year, with 4. The most frequent topics are Breast Neoplasms, Colorectal Neoplasms and Molecular Targeted Therapy. Dr. Ali has published most often in Cureus. Dr. Ali's most frequent co-authors are Long Hoang Dang, MD, PhD, Rohit Bishnoi, MD and Nam Hoang Dang, MD.

CMS Open Payments shows 48 general payments to Dr. Ali from 10 drug and device companies from 2020 to 2025. Consulting fees make up the largest share, 87% of the total. AstraZeneca Pharmaceuticals LP paid the most, $14,835.